ConvitVax is a personalized vaccine for the treatment of breast cancer, composed of autologous tumor cells, bacillus Calmette-Guérin (BCG) and low concentrations of formalin…
Read More...
Research articles
New Study on Breast Cancer
Jacinto Convit World Organization (JCWO) is pleased to announce the publication of their latest work “Evaluation of a ConvitVax/anti-PD-1 combined immunotherapy for breast cancer treatment” in Oncotarget.
Read More...
Jacinto Convit World Organization publishes a relevant study on a new breast cancer immunotherapy
Since its inception, the Jacinto Convit World Organization has strived to help the most vulnerable, be useful to others and work for humanity, by continuing to develop a breast cancer immunotherapy (vaccine) designed by Dr. Jacinto Convit during the last years of his life.
Read More...